The Medical Imaging and Technology Alliance (MITA) recently expressed their displeasure with the Centers for Medicare and Medicaid Services (CMS) coverage decision regarding access to diagnostic testing and treatment of Alzheimer’s Disease. 

Click here to see the full article on the Health Imaging website.